Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,276-1,300 of 2,022
CompletedNCT05686239

A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)

This study exists to compare options and see whether the medication RL-007 offers something meaningfully different. Researchers are trying to understand whether the medication RL-007 can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Bulgaria, Czech Republic, Poland, United States
Sponsor
Recognify Life Sciences
Condition
Schizophrenia
CompletedNCT05905601

mHealth for Psychosis Help-seeking

This study exists to see whether psychoeducation, a guided learning and support program, is workable and worth testing more broadly. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 30 Years
Countries
United States
Sponsor
University of Washington
Condition
Schizophrenia
CompletedNCT04752449

Virtual Cognitive Behavioural Therapy for Psychosis

This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Toronto
Condition
Schizophrenia
CompletedNCT03814967

Effects of Brain Stimulation on Higher-Order Cognition

This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
University of California, Davis
Condition
Schizophrenia
CompletedNCT05703698

EEG Outcomes From Cognitive Behavioural Therapy for Psychosis

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Toronto
Condition
Schizophrenia
CompletedNCT04756388

Examining Strategy Monitoring and Remediation Training

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Toronto
Condition
Schizophrenia
CompletedNCT06226779

Baduanjin Versus Brisk Walking for Cognition in Schizophrenia

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 20 Years to 65 Years
Countries
Taiwan
Sponsor
Chang Gung Memorial Hospital
Condition
Schizophrenia
CompletedNCT03708315

BXCL501 for Agitation in Schizophrenia

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
WithdrawnNCT05469815

Lost Children Society (LCS), Online Therapeutic Tabletop Role-playing Game for Early-onset Schizophrenia Patients

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 15 Years to 20 Years
Countries
Global
Sponsor
Centre Hospitalier Departemental Vendee
Condition
Schizophrenia
CompletedNCT07076940

Mindfulness-Based Education for Caregivers of Individuals Diagnosis With Schizophrenia

This study exists to understand how psychoeducation, a guided learning and support program, holds up over time after the earliest research stage. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can give earlier or clearer feedback during care.

SchizophreniaOtherOver 18 Years
Countries
Turkey
Sponsor
Halic University
Condition
Schizophrenia
CompletedNCT03677635

The Relationship Between Autobiographical Memory and Motivation

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
CompletedNCT05438160

Exploratory Study of a Digital Therapeutics in People With Schizophrenia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
Click Therapeutics, Inc.
Condition
Schizophrenia
CompletedNCT03034356

Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
WithdrawnNCT04761861

Vildagliptin for Treatment of Antipsychotic-induced Dyslipidemia

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Egypt
Sponsor
Sadat City University
Condition
Schizophrenia
CompletedNCT03930225

Effectiveness of A Stigma Directed Interventional Program in Schizophrenia

This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Egypt
Sponsor
Mansoura University
Condition
Schizophrenia
TerminatedNCT05182476

Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Bulgaria, Czech Republic, Serbia, Spain, United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
CompletedNCT00306475

Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia
TerminatedNCT06949657

Occurrence and Influencing Factors of Cognitive Impairment in Elderly Patients With Schizophrenia and

This study exists to explore whether acceptance and commitment therapy, a talking treatment, could improve care and understanding. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 60 Years
Countries
China
Sponsor
Third People's Hospital, Huzhou City, Zhejiang Province, China
Condition
Schizophrenia
CompletedNCT02237235

Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia

This study exists to compare options and see whether the medication MMFS-202 offers something meaningfully different. Researchers are trying to understand whether the medication MMFS-202 can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia
CompletedNCT04282915

Reducing Stigma Among Healthcare Providers (RESHAPE-cRCT)

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.

DepressionOtherOver 16 Years
Countries
Nepal
Sponsor
George Washington University
Condition
Depression
CompletedNCT06284096

The Personal Recovery Based Psychoeducation For Schizophrenia

This study exists to understand what helps psychoeducation, a guided learning and support program, work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Turkey
Sponsor
Istanbul University - Cerrahpasa
Condition
Schizophrenia